We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Court Scraps Counterclaims Against J&J Unit

Law360 (November 13, 2006, 12:00 AM EST) -- A month after upholding the validity and enforceability of a Johnson & Johnson unit’s patent for the antipsychotic drug Risperdal, a New Jersey district court has thrown out a slew of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.